| 1 |
PCR enhancers: Types, mechanisms, and applications in long-range PCR |
|
|
| Harsheni Karunanathie, Ping Siu Kee, Shiow Fern Ng, Martin A. Kennedy, Eng Wee Chua |
|
| Biochimie. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
The racial and ethnic differences in type 2 diabetes mellitus: A black race narrative review |
|
|
| BasilC Ezeokpo, ChidiebereV Ugwueze |
|
| Journal of Diabetology. 2022; 13(1): 25 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine |
|
|
| Radia Hassan, Imane Allali, Francis E Agamah, Samar S M Elsheikh, Nicholas E Thomford, Collet Dandara, Emile R Chimusa |
|
| Briefings in Bioinformatics. 2021; 22(4) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
DRIM: A Web-Based System for Investigating Drug Response at the Molecular Level by Condition-Specific Multi-Omics Data Integration |
|
|
| Minsik Oh, Sungjoon Park, Sangseon Lee, Dohoon Lee, Sangsoo Lim, Dabin Jeong, Kyuri Jo, Inuk Jung, Sun Kim |
|
| Frontiers in Genetics. 2020; 11 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Bioinformatics in translational drug discovery |
|
|
| Sarah K. Wooller, Graeme Benstead-Hume, Xiangrong Chen, Yusuf Ali, Frances M.G. Pearl |
|
| Bioscience Reports. 2017; 37(4) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Finasteride metabolism and pharmacogenetics: new approaches to personalized prevention of prostate cancer |
|
|
| Sarah L Hulin-Curtis, Dominique Petit, W Douglas Figg, Ann W Hsing, Juergen KV Reichardt |
|
| Future Oncology. 2010; 6(12): 1897 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 7 |
Role of pharmacogenomics in the drug development |
|
|
| Suvarna, B.S. |
|
| Kathmandu University Medical Journal. 2009; 7(26): 172-176 |
|
| [Pubmed] [Google Scholar] |
|
